To determine the magnitude, determinants, and public health issues related to diabetic retinopathy (DR) in India using 2019 data from a for-profit telescreening program.
Methods:
Digital retinal images were captured using a nonmydriatic fundus camera and transferred via the telescreening program to a reading center. Ophthalmologists trained in DR image reading created the DR status reports. Age/sex-adjusted rates of DR, sight-threatening DR (STDR), and diabetic macular edema (DME) were calculated and correlated with known risk factors.
Results:
Images of 51,760 Indian diabetic patients (103,520 eyes) were reviewed. The prevalence of DR, STDR, and DME was 19.1% (95% confidence interval [CI]: 18.9–19.5), 5.1% (95% CI: 4.9–5.3), and 3.9% (95% CI: 3.7–4.1), respectively. Based on these data, we projected 14.7 million cases of DR, 3.9 million with STDR, and 3.0 million DME cases in India. Statistically significant risk factors for DR were male gender (odds ratio [OR] = 1.19, p < 0.001), older age (χ2 = 270, df = 3, p < 0.001), history of cataract surgery (OR = 2.0, p < 0.001), longer duration of diabetes (χ2 = 1084, p < 0.001), and type 1 diabetes (OR = 3.9, p = 0.01). There was a statistically significant variation of DR by geographic zones (χ2 = 310, p < 0.001). Laser treatment coverage for STDR was 22%. Duration of diabetes (p < 0.001), cataract surgery in the past (p = 0.02), and females (p = 0.001) were predictors of STDR.
Conclusion:
This model of telescreening for DR provides an additional pathway for screening and preventing diabetes-related visual morbidity in India. The data from this study can be used for epidemiologic and ophthalmic health policies related to diabetes.
Get full access to this article
View all access options for this article.
References
1.
JonasJB, SabanayagamC. Epidemiology and risk factors for diabetic retinopathy. In: Charumathi S, Tien YW, (eds). Diabetic retinopathy and cardiovascular disease. (Vol. 27). Karger Publishers. 2019:20–37.
2.
WillisJR, DoanQV, GleesonM, et al.Vision-related functional burden of diabetic retinopathy across severity levels in the United States. JAMA Ophthalmol, 2017; 135:926–932.
3.
TandonN, AnjanaRM, MohanV, et al.The increasing burden of diabetes and variations among States in India: The Global Burden of diseases Study 1990–2016. Lancet Glob Health, 2018; 6:e1352–e1362.
4.
VermaR, KhannaP, PrinjaS, RajputM, AroraV. The national program for control of blindness in India. Australas Med J, 2011; 4:1–3.
5.
DandonaR, DandonaL, JohnRK, McCartyCA, RaoGN. Awareness of eye diseases in an urban population in southern India. Bull World Health Organ, 2001; 79:96.
6.
GadkariS. Diabetic retinopathy screening: Telemedicine, the way to go! Indian J Ophthalmol 2018;66:187–188.
7.
WangW, LoA. Diabetic retinopathy: Pathophysiology and treatments. Int J Mol Sci, 2018; 19:1816.
8.
ScanlonPH.The English national screening programme for diabetic retinopathy 2003–2016. Acta Diabetol, 2017; 54:515–525.
9.
DaskivichLP, VasquezC, MartinezC, TsengCH, MangioneCM. Implementation and evaluation of a large-scale teleretinal diabetic retinopathy screening program in the Los Angeles County Department of Health Services. JAMA Intern Med, 2017; 177:642–649.
10.
TozerK, WoodwardMA, Newman-CaseyPA. Telemedicine and diabetic retinopathy: Review of published screening programs. J Endocrinol Diabetes, 2015; 2:10.15226/2374-6890/2/4/00131.
11.
ColeED, NovaisEA, LouzadaRN, WaheedNK. Contemporary retinal imaging techniques in diabetic retinopathy: A review. Clin Exp Ophthalmol, 2016; 44:289–299.
12.
TingSW. Diabetic retinopathy screening: Current screening practices and novel retinal imaging modalities. Doctoral dissertation, University of Western Australia. Available at https://api.research-repository.uwa.edu.au/files/7211937/Ting_Shu_Wei_Daniel_2015.pdf (last accessed May5, 2021).
13.
PraveenPA, VenkateshP, TandonN. Screening model for diabetic retinopathy among patients with type 1 diabetes attending a tertiary care setting in India. Indian J Ophthalmol, 2020; 68:96.
14.
GudlavalletiVS, ShuklaR, BatchuT, MalladiBVS, GilbertC. Public health system integration of avoidable blindness screening and management, India. Bull World Health Organ, 2018; 96:705–715.
15.
MurthyGVS, GilbertC, ShuklaR, et al.Overview and project highlights of an initiative to integrate diabetic retinopathy screening and management in the public health system in India. Indian J Ophthalmol, 2020; 68:S12–S15.
NatarajanS, MohanS, SrinivasanR, et al.Diabetic retinopathy-PDR and NPDR prevalence amongst known diabetics and newly detected diabetics in the urban slums of Mumbai. Invest Ophthalmol Vis Sci, 2015; 56:1449-
18.
Welcare system. Tele ophthalmology solutions. Solutions. Available at http://welcaretelemed.com/about-company/ (last accessed January26, 2020).
19.
AnjanaRM, PradeepaR, DeepaM, et al.The Indian Council of Medical Research—India Diabetes (ICMR-INDIAB) study: methodological details. J Diabetes Sci Technol, 2011; 5:906–914.
20.
YadavD, MishraM, TiwariA, BisenPS, GoswamyHM, PrasadGB. Prevalence of dyslipidemia and hypertension in Indian type 2 diabetic patients with metabolic syndrome and its clinical significance. Osong Public Health Res Perspect, 2014; 5:169–175.
21.
BawankarP, ShanbhagN, DhawanB, PalsuleA, KumarD, ChandelS, et al.Sensitivity and specificity of automated analysis of single-field non-mydriatic fundus photographs by Bosch DR algorithm—Comparison with mydriatic fundus photography (ETDRS) for screening in undiagnosed diabetic retinopathy. PLoS One, 2017; 62:e0189854.
22.
WilkinsonCP, Ferris IIIFL, KleinRE, LeePP, AgardhCD, DavisM, et al.Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology, 2003; 110:1677–1682.
23.
American Academy of Ophthalmology. Diabetic Retinopathy Severity Scale in Diabetic Retinopathy Preferred Pattern of Practice. 2019:81. Available at file:///C:/Users/012171/Downloads/Diabetic%20Retinopathy%20PPP%202019.pdf (last accessed March4, 2020).
24.
GilbertC, GordonI, MukherjeeCR, GovindhariV. Guidelines for the prevention and management of diabetic retinopathy and diabetic eye disease in India: A synopsis. Indian J Ophthalmol, 2020; 68:63.
25.
PorwalP, PachadeS, KambleR, KokareM, DeshmukhG, SahasrabuddheV, MeriaudeauF. Indian diabetic retinopathy image dataset (IDRiD): A database for diabetic retinopathy screening research. Data, 2018; 3:25.
26.
List of states and union territories of India by population. Available at https://en.wikipedia.org/wiki/List_of_states_and_union_territories_of_India_by_population (last accessed January28, 2020).
27.
SaeediP, PetersohnI, SalpeaP, et al.Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract, 2019; 157:107843.
28.
National Cancer Institute. Calculating age adjusted rates in Surveillance, Epidemiology & End results program. Available at https://seer.cancer.gov/seerstat/tutorials/aarates/step2.html (last accessed April27, 2020).
29.
RamkeJ, GilbertCE, LeeAC, AcklandP, LimburgH, FosterA. Effective cataract surgical coverage: An indicator for measuring quality-of-care in the context of Universal Health Coverage. PLoS One, 2017; 12:e0172342.
30.
International Diabetes Federation. Diabetes Atlas 9th Edition. Available at https://www.diabetesatlas.org/en/ (last accessed May25, 2020).
31.
WaltonOB, GaroonRB, WengCY, et al.Evaluation of automated teleretinal screening program for diabetic retinopathy. JAMA Ophthalmol, 2016; 134:204–209.
32.
NguyenHV, TanGS, TappRJ, et al.Cost-effectiveness of a national telemedicine diabetic retinopathy screening program in Singapore. Ophthalmology, 2016; 123:2571–2580.
33.
PasquelFJ, HendrickAM, RyanM, CasonE, AliMK, NarayanKV. Cost-effectiveness of different diabetic retinopathy screening modalities. J Diabetes Sci Technol, 2016; 10:301–307.
34.
KhandekarR.Screening and public health strategies for diabetic retinopathy in the Eastern Mediterranean region. Middle East Afr J Ophthalmol, 2012; 19:178.
35.
PooreS, FosterA, ZondervanM, BlanchetK. Planning and developing services for diabetic retinopathy in Sub-Saharan Africa. Int J Health Policy Manag, 2015; 4:19–28.
36.
ChuaJ, LimCXY, WongTY, SabanayagamC. Diabetic retinopathy in the Asia-Pacific. Asia-Pac J Ophthalmol (Phila), 2018; 7:3–16.
37.
SunitaM, SinghAK, RogyeA, et al.Prevalence of diabetic retinopathy in urban slums: The Aditya Jyot diabetic retinopathy in urban Mumbai slums study-report 2. Ophthalmic Epidemiol, 2017; 24:303–310.
38.
RamanR, RaniPK, Reddi RachepalleS, et al.Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology, 2009; 116:311–318.
39.
Kautzky-WillerA, HarreiterJ, PaciniG. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev, 2016; 37:278–316.
40.
RajalakshmiR, BeheraUC, BhattacharjeeH, et al.Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India. Indian J Ophthalmol, 2020; 68:S21–S26.
41.
JosephS, KimR, RavindranRD, FletcherAE, RavillaTD. Effectiveness of teleretinal imaging–based hospital referral compared with universal referral in identifying diabetic retinopathy: A cluster randomized clinical trial. JAMA Ophthalmol, 2019; 137:786–792.
42.
WengC, CoppiniDV, SönksenPH. Geographic and social factors are related to increased morbidity and mortality rates in diabetic patients. Diabet Med, 2000; 17:612–617.
43.
SivaprasadS, GuptaB, Crosby-NwaobiR, EvansJ. Prevalence of diabetic retinopathy in various ethnic groups: A worldwide perspective. Surv Ophthalmol, 2012; 57:347–370.
44.
SolomonSD, ChewE, DuhEJ, et al.Diabetic retinopathy: A position statement by the American Diabetes Association. Diabetes Care, 2017; 40:412–418.
45.
WangSY, AndrewsCA, HermanWH, GardnerTW, SteinJD. Incidence and risk factors for developing diabetic retinopathy among youths with type 1 or type 2 diabetes throughout the United States. Ophthalmology, 2017; 124:424–430.
46.
World Health Organization. Diabetic retinopathy in prevention of avoidable blindness from diabetes mellitus. A report of WHO Consultation in Geneva. 9–11 November. 2005. Geneva, Switzerland. 2006:6. Available at https://www.who.int/blindness/Prevention%20of%20Blindness%20from%20Diabetes%20Mellitus-with-cover-small.pdf (last accessed April27, 2020).
47.
WongTY, SunJ, KawasakiR, et al.Guidelines on diabetic eye care: the International Council of Ophthalmology Recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology, 2018; 125:1608–1622.
48.
PollackA, DotanS, OliverM. Progression of diabetic retinopathy after cataract extraction. Br J Ophthalmol, 1991; 75:547–551.
49.
JengCJ, HsiehYT, YangCM, YangCH, LinCL, WangIJ. Development of diabetic retinopathy after cataract surgery. PLoS One, 2018; 13:e0202347.
50.
PetersonSR, SilvaPA, MurthaTJ, SunJK. Cataract surgery in patients with diabetes: Management strategies. Semin Ophthalmol, 2018; 33:75–82.
51.
KulkarniS, KondalkarS, MactaggartI, et al.Estimating the magnitude of diabetes mellitus and diabetic retinopathy in an older age urban population in Pune, Western India. BMJ Open Ophthalmol, 2019; 4:e000201.
52.
BhikooR, MurrayN, SikivouB, EmmaS, McGheeC. Demographic features and visual outcomes of patients presenting to diabetic photo-screening and treated for sight threatening retinopathy in Fiji. Int J Ophthalmol, 2017; 10:790–795.
53.
ArevaloJF, LasaveAF, WuL, et al.Intravitreal bevacizumab for proliferative diabetic retinopathy. Retina, 2017; 37:334–343.
54.
KeenanTD, JohnstonRL, DonachiePH, SparrowJM, StrattonIM, ScanlonP. United Kingdom National Ophthalmology Database Study: Diabetic retinopathy; report 1: Prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services. Eye, 2013; 27:1397–1404.
55.
PiyasenaMM, YipJL, MacLeodD, KimM, GudlavalletiVS. Diagnostic test accuracy of diabetic retinopathy screening by physician graders using a hand-held non-mydriatic retinal camera at a tertiary level medical clinic. BMC Ophthalmol, 2019; 19:89.
56.
GrimesDA, SchulzKF. Uses and abuses of screening tests. Lancet, 2002; 359:881–884.
57.
KalogeropoulosD, KalogeropoulosC, StefaniotouM, NeofytouM. The role of tele-ophthalmology in diabetic retinopathy screening. J Optom, 2020; S1888–S429630109–8.
58.
RamakrishnanR, KhadarSM, SrinivasanK, KumarH, VijayakumarV. Diabetes mellitus in the Tamil Nadu State—Noncommunicable diseases nurse model in diabetic retinopathy screening. Indian J Ophthalmol, 2020; 68:78.
59.
MurthyGV, VashistP, JohnN, PokharelG, EllweinLB. Prevalence and causes of visual impairment and blindness in older adults in an area of India with a high cataract surgical rate. Ophthalmic Epidemiol, 2010; 17:185–195.
60.
MohanS. Nearly half of Unaware Diabetic Retinopathy patients Detected During Screening in Mumbai Slums. Diabetic Retinopathy and Medical Retina Free Papers. Available at http://proceedings.aios.org/aiosedu/uploads/Diabetic_Retina_15.pdf#page=24 (last accessed April28, 2020).
61.
OlsonJ, SharpP, GoatmanK, PrescottG, ScotlandG, FlemingA, et al.Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: A prospective, multicentre, UK study. Health Technol Assess, 2013; 17:1–142.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
